secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001213900-25-089595
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron enters $10.7M ATM equity offering with H.C. Wainwright
-----------------------------------------------------------------

- Up to $10.7M of Class A common stock may be sold at market prices through agent Wainwright.
- Commission 3.0% of gross proceeds; company reimburses up to $100k legal fees plus periodic diligence fees.
- Net proceeds to fund clinical development of laromestrocel for HLHS, Alzheimer's, and pediatric DCM.
- No minimum sales obligation; company or Wainwright may suspend the offering at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025089595/0001213900-25-089595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025089595/ea0257855-8k_long.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-089595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer